Save your seat


  • Thomas Jostock PhD.
  • Novartis Leading Scientist
  • Novartis Pharma AG, Germany

Thomas graduated from the University of Mainz in Germany, where he finished his PhD thesis in the field of cytokine research in 2001. Thereafter, he joined Dyax in Liege/Belgium, focusing on high throughput re-formatting of phage library derived Fabs to IgG antibodies and mammalian expression vectors before he took a position at the University of Braunschweig in Germany in 2003. During three years in Braunschweig, he was leading a research team working mainly on expression systems for antibodies and antibody fusion proteins. He is still giving lectures as a guest lecturer there. In 2006, Thomas joined the Biotechnology Development Departmant of Novartis in Basel as a Laboratory Head in the Cell Line Development Group. He was awarded Novartis Leading Scientist in 2009 for achievements in enhancing cell line development processes. In 2011, he was appointed New Technology Network Leader and became responsible for coordinating and conducting evaluation studies of external technologies as well as internal technology development programs within the Integrated Biologics Profiling Unit. In 2016, Thomas was appointed Group Head Cell Line Development within the Technical Development NBEs Department. His group is responsible for cell line development from vector design to cell bank characterization for pre-clinical, clinical and commercial manufacturing of the Novartis NBE portfolio, with a focus on non-standard mAb projects.


Delegate fee

from 2196 € Buy